Botfet / Company detail

BMRN

universe

BioMarin Pharmaceutical Inc.

biotech

Moat score60out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic5.6%

Gross Margin77.1%

Revenue Cagr14.9%

Fcf Conversion207.8%

Fcf Yield6.7%

Interest Coverage52.6x

Market Cap B$10.8B

Pe147.2

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant60

Why it may endure

Moat breakdown

Quant: 60 · Curator: 0

Market Share Stability12

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener